Chen, TTL, Rakheja D, Hung JY, Hornsby PJ, Tabaczecoski P, Malogolowkin M, Feusner JH, Miskevich, Schultz R, Tomlinson GE. 2009. Establishment and characterization of a tumor cell line derived from an aggressive childhood liver tumor. Ped. Blood Cancer, in press
Trobaugh-Lotrario AD, Tomlinson GE, Finegold MJ, Gore L, Feusner JH. 2009. Small cell undifferentiated variant of hepatoblastoma: adverse molecular and clinical features similar to rhabdoid tumors, Pediatric Blood and Cancer, 52: 328-34 (cover illustration).
Litten JB and Tomlinson GE. 2008. Liver tumors in children. The Oncologist 13(7):812-820.
Patterson AR, Davis H, Shelby K, McCoy J, Robinson LD, Rao SK, Banerji P, Tominson GE. 2008. Successful strategies for increasing African-American participation in cancer genetics studies: Hopeful signs for equalizing the benefits of genetic medicine. Community Genetics 11:208-214.
Litten JB and Tomlinson GE. 2007. Is preoperative chemotherapy useful for nonmetastatic Wilms’ tumor? Nature Clinical Practice 4:272-3.
Patterson A, Leitch AM, Weatherall P, Zhou XP, Eng E, Tomlinson GE. 2006. “ Multiple findings leading to a diagnosis of a cancer predisposition syndrome: Severe fibrocystic breast disease in a 16-year old female with PTEN hamartoma tumor syndrome (PHTS),” J. Clin. Onc., 24:525-527.
Swinney RM, Wall DA, Grimley MS, Thomas PJ, Taylor C, Tomlinson GE. 2006.“ Familial childhood leukemia cluster with multiple aggressive early-onset hematological malignancies.” Leukemia and Lymphoma, 47:930-932.
Patterson A, Robinson L, Naftalis E, Haley B, Tomlinson GE. 2005. “Custodianship of genetic information: clinical challenges and professional responsibility.” J. Clin. Oncol. 23:2100-2104.
Tomlinson GE, Douglass EC, Pollock BH, Finegold MJ, Schneider NR. 2005 “Cytogenetic analysis of a large series of hepatoblastoma: numerical aberrations with recurring translocations involving 1q12-21.” Genes, Chromosomes and Cancer. 44: 177-84.
TomlinsonGE, Breslow N, Dome J, Guthrie K, Norkool P, Li S, Beckwith JB. Thomas, P, D’Angio G, Green D. 2005. “Rhabdoid tumor of the kidney in the National Wilms’ Tumor Study Group: Age as a prognostic factor,” J. Clin. Onc. 23: 7641-5.
Swinney RM, Hsu S, Hirschman B, Chen TT, Tomlinson GE. 2005. “MDM2 promoter variation and age of onset of acute lymphoblastic leukemia.” Leukemia, 19:1996-8.
Pakakasama S, Chen T, Frawley W, Lee, R, Muller C, Pollock BH, Tomlinson GE. 2004. “Cyclin D1 polymorphism and age of onset of hepatoblastoma.” Oncogene 23:4789-92.
Pakakasama S, Chen T, Frawley W, Muller C, Douglass EC, Tomlinson GE. 2003. “Variation in the myeloperoxidase gene and risk of
hepatoblastoma,” Int. J. Cancer 106:205-7.
Savla J, Chen T, Schneider NR, Timmons C, Delattre O, Tomlinson G. 2000. “Mutation of the hSNF5/INI1 gene in renal rhabdoid tumors with second primary brain tumors.” J. Natl. Cancer Inst. 92:648-650.
Hung J, Mims B, Lozano G, Strong L, Harvey C, Chen, T-Y, Stastny V, Tomlinson G. 1999. “TP53 mutation and haplotype analysis of two large African-American kindreds,” Human Mutation, 14:216-221.
Tomlinson GE, Chen TL, Stastny VA, Virmani A, Spillman MA, Tonk VJ, Blum, JL, Tomlinson GE, Chen TL, Stastny VA, Virmani A, Spillman MA, Tonk VJ, Blum, JL, Schneider NJ, Wistuba I, Minna JD and Gazdar AF. 1998. “Characterization of a breast cancer cell line derived from a germ-line BRCA1 carrier.” Cancer Research, 58:3237-42.
Schneider NR, Cooley LD, Finegold MJ, Douglass EC, Tomlinson GE.1997. “Report of the first recurring chromosome translocation: der(4)t(1;4)(q12;q34).” Genes, Chromosomes and Cancer, 19:291-294.